Crohn's Disease Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1065940
  • May 2021
  • Pharmaceuticals
  • 127 Pages
The Crohn\'s Disease Therapeutics market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Crohn\'s Disease Therapeutics market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered ABBVIE, INC., JOHNSON AND JOHNSON PRIVATE LIMITED, GLAXOSMITHKLINE PLC, MERCK AND CO., INC., NOVARTIS AG, CELGENE CORPORATION, GENENTECH, PFIZER INC., NESTLe HEALTH SCIENCE, BOEHRINGER INGELHEIM GMBH
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Crohn\'s Disease Therapeutics market along with their effects over the forecast period. Similarly, according to the region Crohn\'s Disease Therapeutics market research report includes the study of opportunities available in the market situation.

The Crohn\'s Disease Therapeutics market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Crohn\'s Disease Therapeutics Market:
The Crohn\'s Disease Therapeutics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. ABBVIE, INC., JOHNSON AND JOHNSON PRIVATE LIMITED, GLAXOSMITHKLINE PLC, MERCK AND CO., INC., NOVARTIS AG, CELGENE CORPORATION, GENENTECH, PFIZER INC., NESTLe HEALTH SCIENCE, BOEHRINGER INGELHEIM GMBH

Crohn\'s Disease Therapeutics Market Segmentation Analysis:
By Drug Class
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory drugs
NSAIDs
Corticosteroids
TNF Inhibitors
Aminosalicyclates
Immunomodulators
Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Global Crohn\'s Disease Therapeutics Market Segmentation by Regions:
In regional analysis, Crohn\'s Disease Therapeutics market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Crohn\'s Disease Therapeutics market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Crohn\'s Disease Therapeutics Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Crohn\'s Disease Therapeutics Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Crohn\'s Disease Therapeutics Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Crohn\'s Disease Therapeutics Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Crohn\'s Disease Therapeutics Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Crohn\'s Disease Therapeutics market, according to the key region.
  • To study the Crohn\'s Disease Therapeutics market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Crohn\'s Disease Therapeutics market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Crohn\'s Disease Therapeutics research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Crohn\'s Disease Therapeutics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Crohn\'s Disease Therapeutics market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Crohn\'s Disease Therapeutics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Crohn\'s Disease Therapeutics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Crohn\'s Disease Therapeutics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • ABBVIE, INC.
  • JOHNSON AND JOHNSON PRIVATE LIMITED
  • GLAXOSMITHKLINE PLC
  • MERCK AND CO., INC.
  • NOVARTIS AG
  • CELGENE CORPORATION
  • GENENTECH
  • PFIZER INC.
  • NESTLe HEALTH SCIENCE
  • BOEHRINGER INGELHEIM GMBH
  • Anti-inflammatory Biologics
  • Non-Steroidal Anti-inflammatory drugs
  • NSAIDs
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Crohn's Disease Therapeutics Market Snapshot
          2.1.1. Global Crohn's Disease Therapeutics Market By Drug Class,2019
               2.1.1.1.Anti-inflammatory Biologics
               2.1.1.2.Non-Steroidal Anti-inflammatory drugs
               2.1.1.3.NSAIDs
          2.1.2. Global Crohn's Disease Therapeutics Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacy
               2.1.2.2.Retail Pharmacy
               2.1.2.3.Online Pharmacy
          2.1.3. Global Crohn's Disease Therapeutics Market By End-use,2019
          2.1.4. Global Crohn's Disease Therapeutics Market By Geography,2019

3. Global Crohn's Disease Therapeutics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Crohn's Disease Therapeutics Market Size (US$), By Drug Class, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Drug Class, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Drug Class, 2020
     4.2. Global Crohn's Disease Therapeutics Market Size (US$), By Drug Class, 2018 – 2028

5. Global Crohn's Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Crohn's Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Crohn's Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Crohn's Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028

7. Global Crohn's Disease Therapeutics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Crohn's Disease Therapeutics Market Analysis, 2018 – 2028 
          7.2.1. North America Crohn's Disease Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Crohn's Disease Therapeutics Market Size (US$), By Drug Class, 2018 – 2028
          7.2.3. North America Crohn's Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Crohn's Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Crohn's Disease Therapeutics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Crohn's Disease Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Crohn's Disease Therapeutics Market Size (US$), By Drug Class, 2018 – 2028
          7.3.3. Europe Crohn's Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Crohn's Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Crohn's Disease Therapeutics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Crohn's Disease Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Crohn's Disease Therapeutics Market Size (US$), By Drug Class, 2018 – 2028
          7.4.3. Asia Pacific Crohn's Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Crohn's Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Crohn's Disease Therapeutics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Crohn's Disease Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Crohn's Disease Therapeutics Market Size (US$), By Drug Class, 2018 – 2028
          7.5.3. Latin America Crohn's Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Crohn's Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Crohn's Disease Therapeutics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Crohn's Disease Therapeutics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Crohn's Disease Therapeutics Market Size (US$), By Drug Class, 2018 – 2028
          7.6.3. MEA Crohn's Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Crohn's Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Crohn's Disease Therapeutics Providers
        8.4.1 ABBVIE, INC.
                8.4.1.1 Business Description
                8.4.1.2 ABBVIE, INC. Geographic Operations
                8.4.1.3 ABBVIE, INC. Financial Information
                8.4.1.4 ABBVIE, INC. Product Positions/Portfolio
                8.4.1.5 ABBVIE, INC. Key Developments
        8.4.2 JOHNSON AND JOHNSON PRIVATE LIMITED
                8.4.2.1 Business Description
                8.4.2.2 JOHNSON AND JOHNSON PRIVATE LIMITED Geographic Operations
                8.4.2.3 JOHNSON AND JOHNSON PRIVATE LIMITED Financial Information
                8.4.2.4 JOHNSON AND JOHNSON PRIVATE LIMITED Product Positions/Portfolio
                8.4.2.5 JOHNSON AND JOHNSON PRIVATE LIMITED Key Developments
        8.4.3 GLAXOSMITHKLINE PLC
                8.4.3.1 Business Description
                8.4.3.2 GLAXOSMITHKLINE PLC Geographic Operations
                8.4.3.3 GLAXOSMITHKLINE PLC Financial Information
                8.4.3.4 GLAXOSMITHKLINE PLC Product Positions/Portfolio
                8.4.3.5 GLAXOSMITHKLINE PLC Key Developments
        8.4.4 MERCK AND CO., INC.
                8.4.4.1 Business Description
                8.4.4.2 MERCK AND CO., INC. Geographic Operations
                8.4.4.3 MERCK AND CO., INC. Financial Information
                8.4.4.4 MERCK AND CO., INC. Product Positions/Portfolio
                8.4.4.5 MERCK AND CO., INC. Key Developments
        8.4.5 NOVARTIS AG
                8.4.5.1 Business Description
                8.4.5.2 NOVARTIS AG Geographic Operations
                8.4.5.3 NOVARTIS AG Financial Information
                8.4.5.4 NOVARTIS AG Product Positions/Portfolio
                8.4.5.5 NOVARTIS AG Key Developments
        8.4.6 CELGENE CORPORATION
                8.4.6.1 Business Description
                8.4.6.2 CELGENE CORPORATION Geographic Operations
                8.4.6.3 CELGENE CORPORATION Financial Information
                8.4.6.4 CELGENE CORPORATION Product Positions/Portfolio
                8.4.6.5 CELGENE CORPORATION Key Developments
        8.4.7 GENENTECH
                8.4.7.1 Business Description
                8.4.7.2 GENENTECH Geographic Operations
                8.4.7.3 GENENTECH Financial Information
                8.4.7.4 GENENTECH Product Positions/Portfolio
                8.4.7.5 GENENTECH Key Developments
        8.4.8 PFIZER INC.
                8.4.8.1 Business Description
                8.4.8.2 PFIZER INC. Geographic Operations
                8.4.8.3 PFIZER INC. Financial Information
                8.4.8.4 PFIZER INC. Product Positions/Portfolio
                8.4.8.5 PFIZER INC. Key Developments
        8.4.9 NESTLe HEALTH SCIENCE
                8.4.9.1 Business Description
                8.4.9.2 NESTLe HEALTH SCIENCE Geographic Operations
                8.4.9.3 NESTLe HEALTH SCIENCE Financial Information
                8.4.9.4 NESTLe HEALTH SCIENCE Product Positions/Portfolio
                8.4.9.5 NESTLe HEALTH SCIENCE Key Developments
        8.4.10 BOEHRINGER INGELHEIM GMBH
                8.4.10.1 Business Description
                8.4.10.2 BOEHRINGER INGELHEIM GMBH Geographic Operations
                8.4.10.3 BOEHRINGER INGELHEIM GMBH Financial Information
                8.4.10.4 BOEHRINGER INGELHEIM GMBH Product Positions/Portfolio
                8.4.10.5 BOEHRINGER INGELHEIM GMBH Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Crohn's Disease Therapeutics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Crohn's Disease Therapeutics Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Crohn's Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Crohn's Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Crohn's Disease Therapeutics Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Crohn's Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Crohn's Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Crohn's Disease Therapeutics Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Crohn's Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Crohn's Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Crohn's Disease Therapeutics Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Crohn's Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Crohn's Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Crohn's Disease Therapeutics Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Crohn's Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Crohn's Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Crohn's Disease Therapeutics: Market Segmentation 
FIG. 2 Global Crohn's Disease Therapeutics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Crohn's Disease Therapeutics Market, By Drug Class, 2019 (US$ Mn) 
FIG. 5 Global Crohn's Disease Therapeutics Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Crohn's Disease Therapeutics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Crohn's Disease Therapeutics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Crohn's Disease Therapeutics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Crohn's Disease Therapeutics Providers, 2019
FIG. 11 Global Crohn's Disease Therapeutics Market Revenue Contribution, By Drug Class, 2019 & 2028 (Value %) 
FIG. 12 Global Crohn's Disease Therapeutics Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Crohn's Disease Therapeutics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Crohn's Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Crohn's Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Crohn's Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Crohn's Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Crohn's Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Crohn's Disease Therapeutics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Crohn's Disease Therapeutics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Crohn's Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  North America Crohn's Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  North America Crohn's Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Europe Crohn's Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Crohn's Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Crohn's Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Crohn's Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Crohn's Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Crohn's Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Latin America Crohn's Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Crohn's Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Crohn's Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  MEA Crohn's Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Crohn's Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Crohn's Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  ABBVIE, INC.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  JOHNSON AND JOHNSON PRIVATE LIMITED: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GLAXOSMITHKLINE PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  MERCK AND CO., INC.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  NOVARTIS AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CELGENE CORPORATION: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GENENTECH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  PFIZER INC.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  NESTLe HEALTH SCIENCE: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BOEHRINGER INGELHEIM GMBH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Crohn's Disease Therapeutics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Crohn's Disease Therapeutics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Crohn's Disease Therapeutics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Crohn's Disease Therapeutics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Crohn's Disease Therapeutics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Crohn's Disease Therapeutics Providers, 2016
FIG.  Global Crohn's Disease Therapeutics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Non-Steroidal Anti-inflammatory drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global NSAIDs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Crohn's Disease Therapeutics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Pharmacy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Crohn's Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)